Baudax Bio (BXRXV) News Today → Exposed: 10 CENT Crypto to Explode April 20th? (From True Market Insiders) (Ad) Free BXRXV Stock Alerts $4.51 -1.00 (-18.15%) (As of 11/21/2019) Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineBaudax Bio Inc Ordinary Shares BXRXQmorningstar.com - March 20 at 5:58 PMBaudax Bio Announces Orphan Drug Designation Granted by U.S. FDA for TI-168 for the Treatment of Hemophilia A with Inhibitorsstockhouse.com - September 28 at 8:19 AMNoble Financial Remains a Hold on Baudax Bio (BXRX)markets.businessinsider.com - August 23 at 9:24 AMWhat's Happening With Baudax Bio Shares Todaymsn.com - June 30 at 7:16 PMBaudax Bio Soars on Snapping Up Cell Therapy Developer TeraImmunemsn.com - June 30 at 2:15 PMBaudax Bio Acquires TeraImmune, Inc.finance.yahoo.com - June 30 at 9:10 AMBaudax Bio Touts Additional Positive Data From Nerve Blocker In Surgery Patientsbenzinga.com - June 7 at 3:10 PMBaudax Bio Announces Additional, Positive Top-Line Results From Phase 2 Randomized Clinical Trial of BX1000technews.tmcnet.com - June 7 at 10:09 AMBaudax Bio Announces Date of Reconvened Annual Meetingfinance.yahoo.com - June 6 at 10:15 AMBaudax Bio, Inc.: Baudax Bio Announces Pricing of $4 Million Public Offeringfinanznachrichten.de - April 27 at 8:39 AMBaudax Bio stock dips on pricing $4M stock offering at $1.15/sharemsn.com - April 27 at 8:39 AMBaudax Bio Announces Positive Top-Line Final Results From Phase 2 Randomized Clinical Trial of BX1000finance.yahoo.com - April 25 at 8:52 AMBaudax Bio Announces Positive Results from 2nd Interim Analysis of Phase 2 Randomized Trial for BX1000finance.yahoo.com - March 27 at 8:17 AMWhy Baudax Bio Shares Trading Higher Todayfinance.yahoo.com - January 24 at 2:30 PMBaudax Bio Announces Positive Outcome of Interim Analysis of Phase II Randomized Trial for BX1000finance.yahoo.com - January 24 at 9:29 AMBXRX Baudax Bio, Inc.seekingalpha.com - January 14 at 8:08 AMBaudax Bio Initiates Phase II Clinical Trial Evaluating BX1000 in Patients Undergoing Surgeryfinance.yahoo.com - December 8 at 5:08 PMBaudax Bio Announces Closing of $5 Million Public Offeringnz.finance.yahoo.com - December 6 at 4:56 PMBaudax Bio, Inc.: Baudax Bio Announces Pricing of $5 Million Public Offeringfinanznachrichten.de - December 3 at 9:40 AMBaudax Bio Announces Pricing of $5 Million Public Offeringnz.finance.yahoo.com - December 2 at 3:01 PMBaudax Bio Announces 1-for-40 Reverse Stock Splityahoo.com - November 30 at 6:48 PMBaudax Bio, Inc. (BXRX) Reports Q3 Loss, Lags Revenue Estimatesmsn.com - November 8 at 7:12 PMBaudax Bio Announces Closing of $6.2 Million Public Offeringbenzinga.com - September 1 at 4:20 PMHow Is The Market Feeling About Baudax Bio?msn.com - September 1 at 4:20 PMBaudax Bio Shares Tumble Premarket After Public Offering >BXRXmarketwatch.com - August 30 at 6:31 AMShort Volatility Alert: Baudax Bio, Inc.uk.investing.com - August 27 at 11:54 AMBaudax Bio receives notice of allowance for U.S. Patent Application covering use of ANJESO® for the treatment of moderate to severe painfinance.yahoo.com - August 22 at 9:31 AMBaudax Bio, Inc. (BXRX) Reports Q2 Loss, Misses Revenue Estimatesfinance.yahoo.com - August 11 at 3:35 PMBaudax Bio Reports Second Quarter 2022 Financial Results and Business Highlightsfinance.yahoo.com - August 11 at 3:35 PMBaudax Bio, Inc. (BXRX)finance.yahoo.com - August 8 at 12:54 AMBaudax Bio plunges on launching $2M registered direct offering priced at-the-marketseekingalpha.com - May 18 at 2:57 AMBaudax Bio Announces $2.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rulesstockhouse.com - May 17 at 9:57 PMBaudax Bio Reports First Quarter 2022 Financial Results and Business Highlightsapnews.com - May 4 at 7:46 PMBaudax Bio Q1 2022 Earnings Previewseekingalpha.com - May 4 at 2:46 PMWhat Makes Baudax Bio, Inc. (BXRX) a New Strong Buy Stocknasdaq.com - April 11 at 5:10 PMBaudax Bio Initiates Phase IV Clinical Trial Evaluating ANJESO® in Pediatric Patients Following Surgerynz.finance.yahoo.com - March 8 at 8:30 AMBaudax Bio regains compliance with Nasdaq's listing rulesseekingalpha.com - March 7 at 10:19 AMBaudax Bio wins new U.S. patent for pain therapyseekingalpha.com - March 2 at 3:20 PMBaudax Bio Shares Tumble Premarket on Public Offering >BXRXmarketwatch.com - February 25 at 5:42 PMBaudax Bio Announces Pricing of $10.0 Million Public Offeringyahoo.com - February 25 at 12:57 AMPre-market Movers: STRR, BXRX, CALA, VALN, TKLF…nasdaq.com - January 20 at 8:23 AMBaudax Bio Inc Shares Close the Day 21.9% Lower - Daily Wrapnasdaq.com - December 29 at 9:19 AMBaudax Bio Announces Clinical Program Update for Neuromuscular Blocking Agents BX-1000, BX-2000 and BX-3000finance.yahoo.com - November 11 at 9:16 AMBaudax Bio is about to announce earnings — here's what Wall Street expectsmarkets.businessinsider.com - November 6 at 10:53 PMBaudax Bio to Participate in the Oppenheimer Fall Healthcare Life Sciences & MedTech Summitmorningstar.com - September 16 at 7:52 AMDo Options Traders Know Something About Baudax Bio (BXRX) Stock We Don't?nasdaq.com - August 25 at 4:58 PM Get Baudax Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for BXRXV and its competitors with MarketBeat's FREE daily newsletter. Email Address SHOCKING Crypto Leak… (Ad)A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. BXRXV Media Mentions By Week BXRXV Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BXRXV News Sentiment▼0.000.46▲Average Medical News Sentiment BXRXV News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BXRXV Articles This Week▼00▲BXRXV Articles Average Week Get Baudax Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for BXRXV and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Algernon Pharmaceuticals News ALK-Abelló A/S News Alpha Tau Medical News Arno Therapeutics News Artelo Biosciences News Ascletis Pharma News Awakn Life Sciences News AXIM Biotechnologies News BerGenBio ASA News BriaCell Therapeutics News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:BXRXV) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersSHOCKING Crypto Leak…Crypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingMan Who Predicted 2008: “This Will be Worse.”AltimetryThe Next Nvidia?InvestorPlaceExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersGreat Crypto BullWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Baudax Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
